⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 1995Hemoglobin

Hb A2-Agrinio [δ43(Cd2)Glu→Gly(Gag→Ggg)]: A New δ Chain Variant Detected In A Greek Family

Manoussos N. Papadakis Olga Drakoulakou Elisavet Papapanagiotou D. Pessini A. Loutradi-Anagnostou

View at Publisher

Ask AI

Bookmark

Share

Abstract

(1995). Hb A2-Agrinio [δ43(Cd2)Glu→Gly(Gag→Ggg)]: A New δ Chain Variant Detected In A Greek Family. Hemoglobin: Vol. 19, No. 5, pp. 295-299.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Papadakis et al. (1995) studied this question.

synapsesocial.com/papers/6aa69e97c616a76b5feee891 https://doi.org/10.3109/03630269509005818

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Analysis of delta-globin gene mutations in Greek cypriotsOriginal Research · 1993 · 23 citations
2Delineation of the molecular basis of delta- and normal HbA2 beta- thalassemiaOriginal Research · 1988 · 52 citations
3DNA sequencing with chain-terminating inhibitorsOriginal Research · 1977 · 68,555 citations
4Chemical Characterization of Three Hemoglobins GOriginal Research · 1964 · 51 citations
5Precision Medicine in Sickle Cell Disease: From Molecular Pathways to Curative StrategiesHemoglobin · Thu,

More from Hemoglobin

Endocrine Complications in Patients with Congenital Dyserythropoietic Anemia: A Single-Center Cohort StudyWed,
Metabolomic and Proteomic Profiling of Vaso-Occlusive Crises in Sickle Cell Disease: Current Evidence and Future PerspectivesThu,
Evaluation of a Customized RDB-FTH Panel for β-Globin Variants in a Malaysian Tertiary CenterTue,
CRISPR-Based Mediated Reactivation of Fetal Hemoglobin as a Therapeutic Strategy for Hemoglobinopathies: Evidence from Preclinical to Clinical Trials in Sickle Cell Disease and β-ThalassemiaFri,
Genotype-Specific Hematologic Signatures Across α-Globin Defect Categories in α-ThalassemiaTue,